Linked Data API

Show Search Form

Search Results

753958
star this property registered interest false more like this
star this property date less than 2017-07-19more like thismore than 2017-07-19
star this property answering body
Department of Health more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Radioisotopes: Imports remove filter
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text Her Majesty's Government (1) what assessment they have made of the potential impact of not reaching agreement with the EU by April 2019 on the supply of the radioisotope molybdenum-99 used to produce technetium-99m which is required for over 80 per cent of diagnostic medicine procedures in the UK; (2) what assessment they have made of the potential impact of delays or disruption to the supply of diagnostic medicine procedures that may result; and (3) what contingency plans they have put in place to mitigate such delays or disruption to that supply after Brexit. more like this
star this property tabling member printed
Lord Mendelsohn more like this
star this property uin HL1104 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2017-07-31more like thismore than 2017-07-31
star this property answer text <p>The Government is fully aware of the importance of molybdenum-99 and the reliance on this medical radioisotope for diagnostic procedures in the National Health Service. The United Kingdom’s ability to import medical isotopes from Europe and the rest of the world will not be affected by withdrawal from Euratom. It is in everyone’s interest to not disrupt the timely access of treatment to patients and to ensure that cross-border trade with the European Union and Euratom is as frictionless as possible.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2017-07-31T13:38:56.527Zmore like thismore than 2017-07-31T13:38:56.527Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
4286
unstar this property label Biography information for Lord Mendelsohn more like this
753959
star this property registered interest false more like this
star this property date less than 2017-07-19more like thismore than 2017-07-19
star this property answering body
Department for Exiting the European Union more like this
unstar this property answering dept id 203 more like this
star this property answering dept short name Exiting the European Union more like this
star this property answering dept sort name Exiting the European Union more like this
star this property hansard heading Radioisotopes: Imports remove filter
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text Her Majesty's Government what terms they are seeking to agree with the European Union to ensure that no additional delays or restrictions are placed on imports of molybdenum-99 to the UK following the UK's departure from Euratom. more like this
star this property tabling member printed
Lord Mendelsohn more like this
star this property uin HL1105 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2017-08-02more like thismore than 2017-08-02
star this property answer text <p>The UK’s ability to import medical isotopes from Europe and the rest of the world will not be affected by withdrawal from Euratom.</p><p>The import or export of medical radioisotopes, including molybdenum-99 is not subject to any Euratom licensing requirements.These isotopes are governed and regulated under the Euratom framework; however, Euratom places no restrictions on the export of medical isotopes to countries outside the EU.</p><p>It is in everyone’s interest to not disrupt the timely access of treatment to patients; and to ensure that cross-border trade with the EU and Euratom is as frictionless as possible.</p><p> </p> more like this
star this property answering member printed Baroness Anelay of St Johns more like this
star this property question first answered
less than 2017-08-02T14:39:06.3Zmore like thismore than 2017-08-02T14:39:06.3Z
star this property answering member
3474
star this property label Biography information for Baroness Anelay of St Johns more like this
star this property tabling member
4286
unstar this property label Biography information for Lord Mendelsohn more like this
984272
star this property registered interest false more like this
star this property date less than 2018-10-09more like thismore than 2018-10-09
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Radioisotopes: Imports remove filter
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what progress has been made to secure trade agreements to ensure the security of supply of medical radioisotopes following Brexit. more like this
star this property tabling member printed
Baroness Golding more like this
star this property uin HL10480 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2018-10-17more like thismore than 2018-10-17
star this property answer text <p>The United Kingdom already has robust, domestic regimes in place for the safety, security, transport, use and disposal of nuclear and radioactive materials – including medical radioisotopes – throughout their lifecycle. These regimes will remain in place when Euratom arrangements no longer apply in the UK, ensuring we exit with certainty, clarity and control.</p><p>The Government is continuing to prepare for all European Union exit scenarios and is confident that we will be able to continue to provide a seamless supply of medicines, including medical radioisotopes, to National Health Service patients from the moment we leave the EU.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2018-10-17T15:28:41.257Zmore like thismore than 2018-10-17T15:28:41.257Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
281
unstar this property label Biography information for Baroness Golding more like this
829014
star this property registered interest false more like this
star this property date less than 2018-01-23more like thismore than 2018-01-23
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Radioisotopes: Imports remove filter
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what steps they are taking to ensure that the UK radiopharmaceutical supply after leaving Euratom might be relied upon to not have an impact on patients, in terms of (1) timeliness of delivery, and (2) the quantity supplied of radiopharmaceutical supplies produced (a) in the EU, and (b) outside the EU. more like this
star this property tabling member printed
Lord Carlile of Berriew more like this
star this property uin HL4999 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2018-02-01more like thismore than 2018-02-01
star this property answer text <p>The Government is fully aware of the importance of medical radioisotopes and the reliance on nuclear medicine for diagnostic procedures in the National Health Service. The United Kingdom’s ability to import medical isotopes from Europe and the rest of the world will not be affected by withdrawal from Euratom. It is in the interest of both the UK and European Union to avoid disruption in the timely access of treatment to patients; and to ensure that cross-border trade with the EU is frictionless as possible. This will be part of the broader negotiations of the UK’s future relations with the EU.</p><p> </p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2018-02-01T15:22:50.483Zmore like thismore than 2018-02-01T15:22:50.483Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
1138
unstar this property label Biography information for Lord Carlile of Berriew more like this
1136243
star this property registered interest false more like this
star this property date less than 2019-07-02more like thismore than 2019-07-02
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Radioisotopes: Imports remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what discussions he has had with representatives of suppliers of medical radioisotopes on the feasibility of using air freight to import their products in the event that the UK leaves the EU without a deal. more like this
star this property tabling member constituency Ceredigion more like this
star this property tabling member printed
Ben Lake more like this
star this property uin 272239 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2019-07-10more like thismore than 2019-07-10
star this property answer text <p>The Government maintains that leaving the European Union with a deal is the best exit outcome and has strongly expressed its opposition to leaving without a deal, in line with the position consistently expressed by Parliament. However, leaving without a deal on 31 October 2019 remains the legal default at the end of the Article 50 extension period if no withdrawal agreement is agreed. Therefore, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a ‘no deal’ scenario.</p><p>The Department continues to work closely with the devolved administrations, industry trade bodies and suppliers, the National Health Service and our other main stakeholders to ensure that we are prepared for leaving the EU without a deal in October.</p><p>On 26 June, we wrote to suppliers of medicines to the United Kingdom from or via the EU or wider European Economic Area (EEA) setting out our continuing multi-layered approach to ensure the continuity of supply of all medicines and medical products in a potential ‘no deal’ exit scenario on 31 October. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>We recognise that some medical radioisotopes have a short shelf life and cannot be stockpiled. Therefore, as part of the Department’s contingency planning ahead of a possible March/April 2019 ‘no deal’ scenario, where medical radioisotope products were imported to the UK from the EU or EEA via road haulage and roll-on, roll-off sea, road and rail routes, we asked suppliers to ensure that they had plans in place to air freight those products to avoid any border delays that may have arisen in a no-deal scenario. We worked extensively with these suppliers to ensure plans were in place and are continuing to do so, to ensure that robust contingency arrangements continue to be in place ahead of a possible ‘no deal’ EU exit on 31 October.</p><p> </p><p>The Department has not had discussions with the Civil Aviation Agency in relation to this issue as they are the Government’s expert arm’s length body for the safety, security and economic regulation of civil aviation in the UK. We are, however, working very closely with the Department for Transport.</p>
star this property answering member constituency Wimbledon more like this
star this property answering member printed Stephen Hammond more like this
star this property grouped question UIN
272240 more like this
272241 more like this
star this property question first answered
less than 2019-07-10T16:43:03.51Zmore like thismore than 2019-07-10T16:43:03.51Z
star this property answering member
1585
star this property label Biography information for Stephen Hammond more like this
star this property tabling member
4630
unstar this property label Biography information for Ben Lake more like this
1136245
star this property registered interest false more like this
star this property date less than 2019-07-02more like thismore than 2019-07-02
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Radioisotopes: Imports remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what discussions he has had with the Civil Aviation Authority on the potential risk to the import of medical radioisotopes in the event that the UK leaves the EU without an agreement. more like this
star this property tabling member constituency Ceredigion more like this
star this property tabling member printed
Ben Lake more like this
star this property uin 272241 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2019-07-10more like thismore than 2019-07-10
star this property answer text <p>The Government maintains that leaving the European Union with a deal is the best exit outcome and has strongly expressed its opposition to leaving without a deal, in line with the position consistently expressed by Parliament. However, leaving without a deal on 31 October 2019 remains the legal default at the end of the Article 50 extension period if no withdrawal agreement is agreed. Therefore, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a ‘no deal’ scenario.</p><p>The Department continues to work closely with the devolved administrations, industry trade bodies and suppliers, the National Health Service and our other main stakeholders to ensure that we are prepared for leaving the EU without a deal in October.</p><p>On 26 June, we wrote to suppliers of medicines to the United Kingdom from or via the EU or wider European Economic Area (EEA) setting out our continuing multi-layered approach to ensure the continuity of supply of all medicines and medical products in a potential ‘no deal’ exit scenario on 31 October. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>We recognise that some medical radioisotopes have a short shelf life and cannot be stockpiled. Therefore, as part of the Department’s contingency planning ahead of a possible March/April 2019 ‘no deal’ scenario, where medical radioisotope products were imported to the UK from the EU or EEA via road haulage and roll-on, roll-off sea, road and rail routes, we asked suppliers to ensure that they had plans in place to air freight those products to avoid any border delays that may have arisen in a no-deal scenario. We worked extensively with these suppliers to ensure plans were in place and are continuing to do so, to ensure that robust contingency arrangements continue to be in place ahead of a possible ‘no deal’ EU exit on 31 October.</p><p> </p><p>The Department has not had discussions with the Civil Aviation Agency in relation to this issue as they are the Government’s expert arm’s length body for the safety, security and economic regulation of civil aviation in the UK. We are, however, working very closely with the Department for Transport.</p>
star this property answering member constituency Wimbledon more like this
star this property answering member printed Stephen Hammond more like this
star this property grouped question UIN
272239 more like this
272240 more like this
star this property question first answered
less than 2019-07-10T16:43:03.603Zmore like thismore than 2019-07-10T16:43:03.603Z
star this property answering member
1585
star this property label Biography information for Stephen Hammond more like this
star this property tabling member
4630
unstar this property label Biography information for Ben Lake more like this
1136244
star this property registered interest false more like this
star this property date less than 2019-07-02more like thismore than 2019-07-02
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Radioisotopes: Imports remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what representations he has received from the suppliers of medical radioisotopes on the potential risk to the import of those instruments in the event that the UK leaves the EU without an agreement. more like this
star this property tabling member constituency Ceredigion more like this
star this property tabling member printed
Ben Lake more like this
star this property uin 272240 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2019-07-10more like thismore than 2019-07-10
star this property answer text <p>The Government maintains that leaving the European Union with a deal is the best exit outcome and has strongly expressed its opposition to leaving without a deal, in line with the position consistently expressed by Parliament. However, leaving without a deal on 31 October 2019 remains the legal default at the end of the Article 50 extension period if no withdrawal agreement is agreed. Therefore, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a ‘no deal’ scenario.</p><p>The Department continues to work closely with the devolved administrations, industry trade bodies and suppliers, the National Health Service and our other main stakeholders to ensure that we are prepared for leaving the EU without a deal in October.</p><p>On 26 June, we wrote to suppliers of medicines to the United Kingdom from or via the EU or wider European Economic Area (EEA) setting out our continuing multi-layered approach to ensure the continuity of supply of all medicines and medical products in a potential ‘no deal’ exit scenario on 31 October. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>We recognise that some medical radioisotopes have a short shelf life and cannot be stockpiled. Therefore, as part of the Department’s contingency planning ahead of a possible March/April 2019 ‘no deal’ scenario, where medical radioisotope products were imported to the UK from the EU or EEA via road haulage and roll-on, roll-off sea, road and rail routes, we asked suppliers to ensure that they had plans in place to air freight those products to avoid any border delays that may have arisen in a no-deal scenario. We worked extensively with these suppliers to ensure plans were in place and are continuing to do so, to ensure that robust contingency arrangements continue to be in place ahead of a possible ‘no deal’ EU exit on 31 October.</p><p> </p><p>The Department has not had discussions with the Civil Aviation Agency in relation to this issue as they are the Government’s expert arm’s length body for the safety, security and economic regulation of civil aviation in the UK. We are, however, working very closely with the Department for Transport.</p>
star this property answering member constituency Wimbledon more like this
star this property answering member printed Stephen Hammond more like this
star this property grouped question UIN
272239 more like this
272241 more like this
star this property question first answered
less than 2019-07-10T16:43:03.557Zmore like thismore than 2019-07-10T16:43:03.557Z
star this property answering member
1585
star this property label Biography information for Stephen Hammond more like this
star this property tabling member
4630
unstar this property label Biography information for Ben Lake more like this